About Unit Dose Budesonide MAP Pharmaceuticals is developing Unit Dose Budesonide, a novel version of nebulized budesonide for treating pediatric asthma in children from 12 months to eight years of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback